| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 302.086.745 $ | +340.807 $ | +26,0 % | 9 | 318.645.098 $ | +108.840.266 $ | +60,2 % | 9 | 212.365.525 $ | +56.963.376 $ | +13,8 % | 7 | ||||
| Liquidia Corp | LQDA | → 0 | Stark | 134.056.707 $ | -11.058.209 $ | -7,6 % | 1 | 145.114.916 $ | +46.418.768 $ | +47,0 % | 1 | 98.696.148 $ | +60.070.148 $ | +155,5 % | 1 |
| ESTABLISHMENT LABS HOLDINGS INC. | ESTA | → 0 | Neutral | 56.652.075 $ | -25.735.850 $ | -31,2 % | 1 | 82.387.925 $ | +29.288.659 $ | +55,2 % | 1 | 53.099.266 $ | -5.818.325 $ | -9,9 % | 1 |
| Dave Inc./DE | DAVE | → 0 | Neutral | 29.595.300 $ | +14.096.600 $ | +91,0 % | 1 | 15.498.700 $ | +7.923.400 $ | +104,6 % | 1 | ||||
| Root, Inc. | ROOT | → 0 | Neutral | 16.563.750 $ | -410.300 $ | -2,4 % | 1 | 16.974.050 $ | +11.603.450 $ | +216,1 % | 1 | ||||
| Super Group (SGHC) Ltd | SGHC | → 0 | 16.200.000 $ | +4.967.000 $ | +44,2 % | 1 | 11.233.000 $ | +2.387.693 $ | +27,0 % | 1 | |||||
| Oportun Financial Corp | OPRT | → 0 | Neutral | 12.669.663 $ | -916.644 $ | -6,7 % | 1 | 13.586.307 $ | -2.260.104 $ | -14,3 % | 1 | 15.846.411 $ | -4.461.497 $ | -22,0 % | 1 |
| ODP Corp | → 0 | 14.871.900 $ | -8.787.750 $ | -37,1 % | 1 | ||||||||||
| GEO GROUP INC | GEO | → 0 | Stark | 14.708.750 $ | +4.230.750 $ | +40,4 % | 1 | 10.478.000 $ | -996.400 $ | -8,7 % | 1 | 11.474.400 $ | -2.416.600 $ | -17,4 % | 1 |
| Turning Point Brands, Inc. | TPB | → 0 | Neutral | 13.766.800 $ | +4.869.400 $ | +54,7 % | 1 | 8.897.400 $ | +8.897.400 $ | 1 | |||||
| Abivax S.A. | ABVX | → 0 | Sehr schwach | 11.691.750 $ | +5.218.710 $ | +80,6 % | 1 | ||||||||
| CENOVUS ENERGY INC. | CVE | → 0 | Neutral | 9.948.750 $ | +9.948.750 $ | 1 | |||||||||
| Celsius Holdings, Inc. | CELH | → 0 | Sehr schwach | 9.605.400 $ | +9.605.400 $ | 1 | |||||||||
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Neutral | 9.480.000 $ | +9.480.000 $ | 1 | |||||||||
| 302.086.745 $ | +340.807 $ | +26,0 % | 9 | 318.645.098 $ | +108.840.266 $ | +60,2 % | 9 | 212.365.525 $ | +56.963.376 $ | +13,8 % | 7 | ||||